Emotions in the Communication and Relationship Styles of Parents With Hemophilic Children.

Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Other)
Overall Status
Recruiting
CT.gov ID
NCT05754619
Collaborator
(none)
10
1
7
1.4

Study Details

Study Description

Brief Summary

Severe hemophilia is a rare, inherited, X-linked disorder. Currently, standard therapy involves ev infusion of drugs from a very young age.

The diagnosis of hemophilia is a traumatic event for the parents, even before the unborn child. The management of the hemophilia patient involves the whole family. Also in relation to its heredity.Focus on the ways in which parents of children with hemophilia manage their emotional experience.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Severe hemophilia is a rare, inherited, X-linked disorder. Currently, standard therapy involves ev infusion of drugs from a very young age.The diagnosis of hemophilia is a traumatic event for the parents, even before the unborn child. The management of the hemophilia patient involves the whole family. Also in relation to its heredity.Focus on the ways in which parents of children with hemophilia manage their emotional experience.he diagnosis of hemophilia brings with it, in parents, fears, guilt, overprotective temptations that push us to act rather than to narrate the meaning of that need of ours, caregiving modes that risk engaging our operational side at the expense of recognizing ourselves and our feelings and emotions. We have no reason to think that that traumatic stimulus installs in us an atypical mode of resorting to our emotional intelligence. Therefore, it becomes even more significant to study parent-child communication processes on this target, to observe whether and how the adult's emotional area finds its place and expression. On the results of this work, the foundations could be laid for subsequent observational or interventional studies.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    10 participants
    Observational Model:
    Cohort
    Time Perspective:
    Other
    Official Title:
    Le Emozioni Negli Stili di Comunicazione e Relazione di Genitori Con Figli Emofilici.
    Actual Study Start Date :
    Oct 14, 2022
    Anticipated Primary Completion Date :
    May 14, 2023
    Anticipated Study Completion Date :
    May 14, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    patients with HA

    20 parents with hemophilic children. The sample will consist of 10 mothers and 10 fathers.

    Outcome Measures

    Primary Outcome Measures

    1. The study aims to highlight the ways in which the caregivers of haemophiliac children and young people manage and express their emotional experience through interviews and reports [1 month]

      The study aims to highlight the ways in which care givers of hemophilic children and youth manage and express their emotional experiences. It therefore intends to answer these questions: How do parents of hemophilic children and youth contribute to the development of their children's emotional intelligence? What adult role model do they consciously or unconsciously propose in relation to frailties and fears? How do they guide their children in dealing with frailties and fears? Does the communication process they construct integrate their experience and is it congruent with it?

    Secondary Outcome Measures

    1. opportunity for mirroring the parents interviewed by which they construct participation in their child's life in the experience of illness with interview and questionnaire. [3 months]

      This study represents a potential opportunity for mirroring the interviewed parents, who in nonjudgmental observation will be able to see themselves and the unconscious dynamics by which they construct participation in their child's life in the experience of illness. Where interviewed parents show willingness and interest, a thirty-minute follow-up meeting will be held fifteen days/one month later, which will aim to accommodate their experience following the stimuli offered by the experience with our team. The main purpose, then, is in accompanying these people to process what will have emerged in the interview-interview

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    10 Years to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Haemophilia A
    Exclusion Criteria:
    • No Informed Conset

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 FPG Roma Italy 00168

    Sponsors and Collaborators

    • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    Investigators

    • Principal Investigator: Raimondo De Cristofaro, MD, Fondazione Policlinico Universitario A.Gemelli IRCCS Rome

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    De Cristofaro Raimondo, Prof. Raimondo De Cristofaro, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    ClinicalTrials.gov Identifier:
    NCT05754619
    Other Study ID Numbers:
    • 4913
    First Posted:
    Mar 6, 2023
    Last Update Posted:
    Mar 6, 2023
    Last Verified:
    Feb 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 6, 2023